240 related articles for article (PubMed ID: 31636293)
1. Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1).
Singh N; Villoutreix BO; Ecker GF
Sci Rep; 2019 Oct; 9(1):15061. PubMed ID: 31636293
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.
Singh N; Ecker GF
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695141
[TBL] [Abstract][Full Text] [Related]
3. Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).
Chien HC; Colas C; Finke K; Springer S; Stoner L; Zur AA; Venteicher B; Campbell J; Hall C; Flint A; Augustyn E; Hernandez C; Heeren N; Hansen L; Anthony A; Bauer J; Fotiadis D; Schlessinger A; Giacomini KM; Thomas AA
J Med Chem; 2018 Aug; 61(16):7358-7373. PubMed ID: 30048132
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods.
Singh N; Scalise M; Galluccio M; Wieder M; Seidel T; Langer T; Indiveri C; Ecker GF
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577601
[TBL] [Abstract][Full Text] [Related]
5. Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation.
Kärkkäinen J; Laitinen T; Markowicz-Piasecka M; Montaser A; Lehtonen M; Rautio J; Gynther M; Poso A; Huttunen KM
Bioorg Chem; 2021 Jul; 112():104921. PubMed ID: 33933805
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.
Ilgü H; Jeckelmann JM; Colas C; Ucurum Z; Schlessinger A; Fotiadis D
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558430
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands.
Huttunen J; Agami M; Tampio J; Montaser AB; Huttunen KM
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011270
[TBL] [Abstract][Full Text] [Related]
8. Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.
Kärkkäinen J; Gynther M; Kokkola T; Petsalo A; Auriola S; Lahtela-Kakkonen M; Laine K; Rautio J; Huttunen KM
Int J Pharm; 2018 Jun; 544(1):91-99. PubMed ID: 29669256
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion.
Ylikangas H; Peura L; Malmioja K; Leppänen J; Laine K; Poso A; Lahtela-Kakkonen M; Rautio J
Eur J Pharm Sci; 2013 Feb; 48(3):523-31. PubMed ID: 23228412
[TBL] [Abstract][Full Text] [Related]
10. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
Yan R; Zhao X; Lei J; Zhou Q
Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
[TBL] [Abstract][Full Text] [Related]
11. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.
Uchino H; Kanai Y; Kim DK; Wempe MF; Chairoungdua A; Morimoto E; Anders MW; Endou H
Mol Pharmacol; 2002 Apr; 61(4):729-37. PubMed ID: 11901210
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5). Probing critical residues for substrate translocation.
Napolitano L; Galluccio M; Scalise M; Parravicini C; Palazzolo L; Eberini I; Indiveri C
Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):727-736. PubMed ID: 28088504
[TBL] [Abstract][Full Text] [Related]
13. Grafted hyaluronic acid N-acetyl-l-methionine for targeting of LAT1 receptor: In-silico, synthesis and microscale thermophoresis studies.
Waddad AY; Ramharack P; Soliman MES; Govender T
Int J Biol Macromol; 2019 Mar; 125():767-777. PubMed ID: 30553855
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity characteristics of phenylalanine analogs selectively transported by L-type amino acid transporter 1 (LAT1).
Chen S; Jin C; Ohgaki R; Xu M; Okanishi H; Kanai Y
Sci Rep; 2024 Feb; 14(1):4651. PubMed ID: 38409393
[TBL] [Abstract][Full Text] [Related]
15. Amino acid ester prodrugs conjugated to the α-carboxylic acid group do not display affinity for the L-type amino acid transporter 1 (LAT1).
Rautio J; Kärkkäinen J; Huttunen KM; Gynther M
Eur J Pharm Sci; 2015 Jan; 66():36-40. PubMed ID: 25305508
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1).
Kongpracha P; Nagamori S; Wiriyasermkul P; Tanaka Y; Kaneda K; Okuda S; Ohgaki R; Kanai Y
J Pharmacol Sci; 2017 Feb; 133(2):96-102. PubMed ID: 28242177
[TBL] [Abstract][Full Text] [Related]
17. Computational Study Reveals the Role of Water Molecules in the Inhibition Mechanism of LAT1 by 1,2,3-Dithiazoles.
Prejanò M; Romeo I; La Serra MA; Russo N; Marino T
J Chem Inf Model; 2021 Dec; 61(12):5883-5892. PubMed ID: 34788052
[TBL] [Abstract][Full Text] [Related]
18. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
Lu X
Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
[TBL] [Abstract][Full Text] [Related]
19. Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).
Ylikangas H; Malmioja K; Peura L; Gynther M; Nwachukwu EO; Leppänen J; Laine K; Rautio J; Lahtela-Kakkonen M; Huttunen KM; Poso A
ChemMedChem; 2014 Dec; 9(12):2699-707. PubMed ID: 25205473
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitylation and endocytosis of the human LAT1/SLC7A5 amino acid transporter.
Barthelemy C; André B
Sci Rep; 2019 Nov; 9(1):16760. PubMed ID: 31728037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]